Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simonovation is a private consulting firm founded by Greg Simon that advises on science, innovation, technology, and healthcare policy issues. The firm appears to operate primarily as a strategic advisory business rather than a drug developer, with work spanning healthcare affordability, medical research, patient advocacy, and policy reform. Public references consistently describe Simonovation as an international consulting firm in science and technology policy, with particular relevance to healthcare and life sciences strategy. Based on available information, the company does not appear to have a therapeutic pipeline, clinical-stage assets, or proprietary drug programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Simonovation.